PEPTIDE FRAGMENTS OF MURINE EPIDERMAL GROWTH FACTOR AS LAMININ RECEPTOR TARGETS

摘要

The present invention provides the use of natural, synthetic or modified peptide factors derived from murine epidermal growth factor in the treatment of angiogenic diseases by targeting laminin receptors. The invention provides agonists and antagonists which may be modified to prevent proteolytic degradation. Use of the invention to treat retinopathy of prematurity and promote wound healing is envisaged.